CAPRISA

CAPRISA
Purpose AIDS research
Location
Director
 Salim Abdool Karim
Website http://www.caprisa.org/


CAPRISA ("Centre for the AIDS Programme of Research in South Africa") is the name of an AIDS research center based in Durban, South Africa.

History

CAPRISA was established in 2002 under the National Institutes of Health program called Comprehensive International Program of Research on AIDS (CIPRA). Five partner institutions participated in the founding: University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute of Communicable Diseases, and Columbia University in New York. UNAIDS recognizes CAPRISA with the designation of "Collaborating Centre for HIV Prevention Research."[1]

CAPRISA's mission is to promote HIV prevention and research its epidemiology.[1]

CAPRISA 004

Main article: CAPRISA 004

CAPRISA 004 is the name of a clinical trial testing a microbicide which was experimentally shown to be effective in reducing women's risk of contracting HIV.[2]

References

  1. 1 2 "Founding of CAPRISA". CAPRISA. Retrieved 23 January 2011.
  2. ↑ Celia W. Dugger (19 July 2010). "African Studies Give Women Hope in H.I.V. Fight". The New York Times. Retrieved 23 January 2011.

External links

This article is issued from Wikipedia - version of the Monday, April 11, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.